120 related articles for article (PubMed ID: 35150349)
1. C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery.
Ishiyama Y; Kondo T; Ishihara H; Yoshida K; Iizuka J; Tanabe K; Takagi T
Int J Clin Oncol; 2022 May; 27(5):969-976. PubMed ID: 35150349
[TBL] [Abstract][Full Text] [Related]
2. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
de Martino M; Klatte T; Seemann C; Waldert M; Haitel A; Schatzl G; Remzi M; Weibl P
BJU Int; 2013 Jun; 111(8):E348-53. PubMed ID: 23495750
[TBL] [Abstract][Full Text] [Related]
3. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC).
Patel SH; Derweesh IH; Saito K; Patil D; Meagher MF; Bindayi A; Eldefrawy A; Patel DN; Nasseri R; Yasuda Y; Fujii Y; Master VA
Clin Genitourin Cancer; 2021 Aug; 19(4):e206-e215. PubMed ID: 33773937
[TBL] [Abstract][Full Text] [Related]
5. Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival.
Teishima J; Ohara S; Shinmei S; Inoue S; Hayashi T; Mochizuki H; Mita K; Shigeta M; Matsubara A
Urol Oncol; 2018 Jul; 36(7):339.e9-339.e15. PubMed ID: 29773493
[TBL] [Abstract][Full Text] [Related]
6. The SSPN Score, a Novel Scoring System Incorporating PBRM1 Expression, Predicts Postoperative Recurrence for Patients with Non-metastatic Clear Cell Renal Cell Carcinoma.
Ohsugi H; Yoshida T; Ohe C; Ikeda J; Sugi M; Kinoshita H; Tsuta K; Matsuda T
Ann Surg Oncol; 2021 Apr; 28(4):2359-2366. PubMed ID: 32940805
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma.
Wang B; Gu W; Wan F; Shi G; Ye D
Int Braz J Urol; 2019; 45(1):89-99. PubMed ID: 29570259
[TBL] [Abstract][Full Text] [Related]
8. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
9. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
[TBL] [Abstract][Full Text] [Related]
10. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
11. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit.
Lu J; Xu BB; Xue Z; Xie JW; Zheng CH; Huang CM; Li P
Cancer Med; 2021 Jan; 10(1):34-44. PubMed ID: 33270989
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
[TBL] [Abstract][Full Text] [Related]
14. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
15. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
Omae K; Kondo T; Tanabe K
Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
[TBL] [Abstract][Full Text] [Related]
16. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
17. Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.
Michigan A; Johnson TV; Master VA
Mol Diagn Ther; 2011 Aug; 15(4):229-34. PubMed ID: 21756006
[TBL] [Abstract][Full Text] [Related]
18. Impact of rhabdoid differentiation on postoperative outcome for patients with N0M0 renal cell carcinoma.
Kim H; Inomoto C; Uchida T; Kajiwara H; Komiyama T; Kobayashi H; Nakamura N; Miyajima A
Urol Oncol; 2019 Oct; 37(10):711-720. PubMed ID: 31174957
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
[TBL] [Abstract][Full Text] [Related]
20. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
